{"id":"W2042379375","doi":"10.1158/0008-5472.sabcs-09-4095","title":"A Phase II Study (FINDER 2) Comparing Three Dosing Regimens of Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Medicine; Tolerability; Discontinuation; Breast cancer; Internal medicine; Dosing; Cancer; Hazard ratio; Oncology; Urology; Estrogen receptor; Gastroenterology; Confidence interval; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001917375,0.001250383,0.001848724,0.0005481165,0.0003564502,0.0006512251,0.0007212854,0.0011639,0.004000736],"category_scores_gemma":[0.001447976,0.0006516026,0.001151262,0.0004094618,0.0009315592,0.0008207302,0.0003689955,0.001982939,0.0006355688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005565786,"about_ca_system_score_gemma":0.0009887825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005046988,"about_ca_topic_score_gemma":0.0009741149,"domain_scores_codex":[0.9994398,0.0003189085,0.00003320276,0.0000993432,0.00004398971,0.00006480217],"domain_scores_gemma":[0.9991236,0.0002674935,0.000231292,0.0000976191,0.00004128024,0.0002386295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8975993,0.04570609,0.002906033,0.000409119,0.0006731301,0.00007042569,0.0001275722,0.0010291,0.01765785,0.0001316502,0.0007514298,0.03293838],"study_design_scores_gemma":[0.6787418,0.3155665,0.003066648,0.00001069245,0.0002323777,0.00006066067,0.0000198565,0.0002954021,0.001363,0.00008718157,0.0005447228,0.00001111542],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937724,0.001210664,0.000537661,0.000201344,0.00009304633,0.002774349,0.0006405057,0.00006588069,0.0007041698],"genre_scores_gemma":[0.9878811,0.001404208,0.002479219,0.0006894589,0.0002659204,0.004275999,0.001121113,0.0000271365,0.001855803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004000736,"threshold_uncertainty_score":0.01338375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05101035564151347,"score_gpt":0.4096415934897822,"score_spread":0.3586312378482688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}